|
| Press Releases |
|
 |
|
| Friday, June 30, 2023 |
|
|
中国三大ICL服务提供商之一艾迪康于香港联交所主板正式挂牌 |
据弗若斯特沙利文，截至2020年、2021年和2022年12月31日三个年度的总营收计算，中国三大独立医学实验室（「ICL」）服务提供商之一 ── 艾迪康控股有限公司（「艾迪康」或「公司」；股份代号：9860.HK），今天于香港联合交易所有限公司（「联交所」）主板正式上市并开始买卖，每手买卖单位为500股。
more info >> |
|
|
中國三大ICL服務提供者之一艾迪康於香港聯交所主板正式掛牌 |
| 據弗若斯特沙利文，截至2020年、2021年和2022年12月31日三個年度的總營收計算，中國三大獨立醫學實驗室（「ICL」）服務提供者之一 ── 艾迪康控股有限公司（「艾迪康」或「公司」；股份代號：9860.HK），今天於香港聯合交易所有限公司（「聯交所」）主板正式上市並開始買賣，每手買賣單位為500股。 more info >> |
|
|
ADICON Holdings Limited One of the Top Three ICL Service Providers in China is Successfully Listed on Main Board of SEHK |
| ADICON Holdings Limited ("ADICON" or "Company", stock code: 9860.HK), one of the top three independent clinical laboratory ("ICL") service providers in China in terms of total revenues during the three years ended 31 December 2020, 2021 and 2022, according to Frost & Sullivan more info >> |
|
| Wednesday, June 21, 2023 |
|
|
医疗板块布局正当时，关注新股ICL龙头艾迪康带来的投资机遇 |
| 6月以来，香港股市迎来强势反弹，恒指累升1,806点。周末收市重返二万点之上，是逾1个月以来首次。 more info >> |
|
|
醫療板塊佈局正當時，關注新股ICL龍頭艾迪康帶來的投資機遇 |
| 6月以來，香港股市迎來強勢反彈，恒指累升1,806點。週末收市重返二萬點之上，是逾1個月以來首次。 more info >> |
|
| Monday, June 19, 2023 |
|
|
艾迪康宣布于港交所主板上市计划 每股作价12.32港元 |
| 中国独立医学实验室（「ICL」）的开拓者及中国三大ICL服务提供商之一 ── 艾迪康控股有限公司（「艾迪康」或「公司」；股份代号：9860.HK），今天宣布于香港联合交易所有限公司（「联交所」）主板上市计划。 more info >> |
|
|
艾迪康宣佈於港交所主板上市計劃 每股作價12.32港元 |
| 中國獨立醫學實驗室（「ICL」）的開拓者及中國三大ICL服務提供者之一 ── 艾迪康控股有限公司（「艾迪康」或「公司」；股份代號：9860.HK），今天宣佈於香港聯合交易所有限公司（「聯交所」）主板上市計劃。 more info >> |
|
|
ADICON Announces Proposed Listing on the Main Board of The Stock Exchange of Hong Kong at an Offer Price of HK$12.32 Per Share |
ADICON Holdings Limited ("ADICON" or "Company", stock code: 9860.HK), the pioneer of independent clinical laboratory ("ICL") and one of the top three ICL service providers in China, today announced the proposed listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK").
more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
UNFPA and NEC Collaborate to Build Beneficiary Information Management and e-Voucher System
Aug 18, 2025 14:38 JST
|
|
|
Shoucheng Portfolio Wins 37 Medals at Humanoid Robot Games
Aug 18, 2025 10:35 HKT/SGT
|
|
|
The Business Show Asia 2025 Set to Inspire, Connect, and Transform Businesses
Aug 18, 2025 10:30 HKT/SGT
|
|
|
勇奪12金14銀11銅 首程控股多家被投企業閃耀世界人形機器人運動會
Aug 18, 2025 10:23 HKT/SGT
|
|
|
Anime Tokyo Station Surpasses 200,000 Visitors
Aug 18, 2025 11:00 JST
|
|
|
斩获12金14银11铜 摘得大满贯！首程控股多家被投企业闪耀世界人形机器人运动会
Aug 18, 2025 09:57 HKT/SGT
|
|
|
Eisai Launches In-House Developed Anti-Insomnia Drug DAYVIGO(R) (Lemborexant) in China
Aug 18, 2025 9:11 JST
|
|
|
RAK ICC Strengthens Foundations Regime with 2025 Legislative Enhancements
Aug 16, 2025 15:27 HKT/SGT
|
|
|
WL Delicious Announced 2025 Interim Results
Aug 16, 2025 15:25 HKT/SGT
|
|
|
MMG Announces 2025 Interim Results, Profit, Earnings and Cash up on Strong Copper Growth
Aug 16, 2025 14:55 HKT/SGT
|
|
|
Formerra Becomes North American Distributor for Syensqo PVDF
Aug 16, 2025 14:55 HKT/SGT
|
|
|
Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products
Aug 16, 2025 14:54 HKT/SGT
|
|
|
How Do AI Workflow Automations Work?
Aug 16, 2025 00:00 HKT/SGT
|
|
|
Everest Medicines' New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access
Aug 15, 2025 23:18 HKT/SGT
|
|
|
Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC
Aug 15, 2025 20:15 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
